Back to search

The role of 123I‐diagnostic imaging in the follow‐up of patients with differentiated thyroid carcinoma as compared to 131I‐scanning: avoidance of negative therapeutic uptake due to stunning

Data up to Jan 2025

Published2001
Citations57
References26

Total Citations Per Year

Abstract

References (26)

Long-Term Results of Treatment of 283 Patients with Lung and Bone Metastases from Differentiated Thyroid Carcinoma

1986 • 557 citations

Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.

1995 • 320 citations

THYROTROPHIN-RELEASING HORMONE AS A THYROID-FUNCTION TEST

1971 • 280 citations

Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.

1987 • 251 citations

Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.

1994 • 242 citations

MICROGNATHIA

1947 • 224 citations

Influence of Diagnostic Radioiodines on the Uptake of Ablative Dose of Iodine-131

1994 • 219 citations

Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays.

1988 • 196 citations

Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan

1995 • 160 citations

Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.

1987 • 150 citations

Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma

1998 • 143 citations

Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer

1994 • 140 citations

Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.

1994 • 135 citations

Detection of Thyroid Remnant/Metastasis Without Stunning: An Ongoing Dilemma

1997 • 131 citations

The significance of 1-131 scan dose in patients with thyroid cancer: determination of ablation: concise communication.

1981 • 92 citations

Dosimetric Considerations in the Radioiodine Treatment of Macrometastases and Micrometastases from Differentiated Thyroid Cancer

1997 • 83 citations

Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan.

1996 • 80 citations

The Bart's endocrine protocols

1995 • 57 citations

Sliding mode controller with filtered signal for robot manipulators using virtual plant/controller

1997 • 53 citations

Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.

1991 • 52 citations

Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan

1996 • 49 citations

Serum thyroglobulin measurements in thyroid cancer: evaluation of‘false’ positive results

1991 • 37 citations

Radioimmunoscintigraphy in tumour identification.

1987 • 28 citations

The usefulness of serum thyroglobulin in the follow‐up of differentiated thyroid carcinoma in children

1992 • 23 citations

Application of α-aminoisobutyric acid,l-methionine, thymidine and 2-fluoro-2-deoxy-d-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line

1996 • 18 citations

Highlights Lecture of the European Association of Nuclear Medicine and the World Federation of Nuclear Medicine and Biology Congress, Berlin 1998

1998 • 9 citations

Cited By (0)

Loading...